Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma-Bio ServPBSV -27.16%43 Days Payable is 46.84 as of Apr. 2026, which is 11% below its 10-year median of 52.34. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 606 Healthcare Providers & Services companies, Pharma-Bio Serv ranks worse than 50.66% on this metric.
The historical rank and industry rank for Pharma-Bio Serv's Days Payable or its related term are showing as below:
PBSV'
s Days Payable Range Over the Past 10 Years
Min: 43.37 Med: 52.34 Max: 67.72
Current: 55.09
During the past 13 years, Pharma-Bio Serv's highest Days Payable was 67.72. The lowest was 43.37. And the median was 52.34.
PBSV's Days Payable is ranked worse than 50.66% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.015
vs PBSV: 55.09
Pharma-Bio Serv's Days Payable
declined
from Apr. 2025 (53.96) to Apr. 2026 (46.84).
It may suggest that Pharma-Bio Servaccelerated paying its suppliers.
The historical data trend for Pharma-Bio Serv's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pharma-Bio Serv's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Days Payable distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Pharma-Bio Serv's Days Payable for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv (PBSV) has a Days Payable of 46.84 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharma-Bio Serv and its competitors. This is 11% below median its historical median of 52.34. Over the past decade, Pharma-Bio Serv's Days Payable has ranged from 43.37 to 67.72. According to the industry distribution chart, Pharma-Bio Serv ranks #307 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 50.7%.
Is Pharma-Bio Serv's Days Payable too high?
Pharma-Bio Serv's current Days Payable of 46.84 is 11% below median its 10-year median of 52.34. Over the past 10 years, this metric has ranged from a low of 43.37 to a high of 67.72. The Healthcare Providers & Services industry median Days Payable is 57.02. Pharma-Bio Serv's value of 46.84 is 17.8% below this industry median. Based on the distribution chart, Pharma-Bio Serv ranks #307 out of 606 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Days Payable compare to MGRX and BFRG?
According to the Healthcare Providers & Services industry distribution chart, Pharma-Bio Serv ranks #307 out of 606 companies for Days Payable. This places Pharma-Bio Serv in the lower half of its industry. The industry median Days Payable is 57.02. Pharma-Bio Serv's value of 46.84 is 17.8% below this benchmark. Historically, Pharma-Bio Serv's own Days Payable has ranged from 43.37 to 67.72 over the past decade. While the company's 10-year median is 52.34 vs. the industry median of 57.02, Pharma-Bio Serv has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.02, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma-Bio Serv's current Days Payable of 46.84 is 17.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pharma-Bio Serv and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma-Bio Serv's current Days Payable is 46.84, which is 11% below median its own 10-year median of 52.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current Days Payable is 46.84, which is 11% below median its 10-year median of 52.34 and 17.8% below the Healthcare Providers & Services industry median of 57.02. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Days Payable is 46.84 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma-Bio Serv (PBSV) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued.
The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58.
GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.
Key valuation signals for PBSV:
Days Payable: 46.84 (11% below median its 10-year median of 52.34)
GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
Industry Position: 17.8% below the Healthcare Providers & Services median (#307 of 606)
No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score
Get the complete analysis for PBSV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBSV has been successfully added to your 
